Search Within

Mark Andrew Dickson

Formats
  1. Journal Article (84)
  2. Meeting Abstract (83)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (169)
  2. Sarcoma Service (169)
  3. Solid Tumor Oncology Division (169)
  4. GSK Faculty (92)
  5. Hematologic Malignancies, Division of (86)
  6. Tow Center for Developmental Oncology (TCDO) (78)

More Groups

People
  1. William Tap (90)
  2. Sandra D'Angelo (83)
  3. Mary Keohan (75)
  4. Mrinal Gounder (69)
  5. Li-Xuan Qin (56)
  6. Ping Chi (54)

More People

Years
  1. 2025 (3)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Clinical Cancer Research (17)
  3. Annals of Oncology (8)
  4. European Journal of Cancer (5)
  5. Nature Communications (5)
  6. The Oncologist (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (14)
  4. Oxford University Press (13)
  5. Nature Publishing Group (10)
  6. Springer (6)

More Publishers

Results (169)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GLI1 co-amplification in well-differentiated / dedifferentiated liposarcomas: A clinicopathologic and molecular analysis of 89 cases
    Meeting Abstract

    Sharma, A.; Dickson, M.; Hameed, M.; Center, M.; Agaram, N.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I trial of CRD3874-SI, a systemically administered STING agonist, in patients with advanced solid tumors
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; Clark, C.; Counihan, O.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • GLI1 coamplification in well-differentiated/dedifferentiated liposarcomas: Clinicopathologic and molecular analysis of 92 cases
    Journal Article

    Sharma, A. E.; Dickson, M.; Singer, S.; Hameed, M. R.; Agaram, N. P.
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Phase II trial of nab- sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (AMPECT): Long-term efficacy and safety update
    Journal Article

    Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K.; Van Tine, B. A.; Chugh, R.; Cranmer, L.; Gordon, E. M.; Hornick, J. L.; Du, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Response to treatment with nab-sirolimus among patients with primary uterine PEComa: A sub analysis from AMPECT
    Meeting Abstract

    Palma, N.; Navarro, W.; Ravi, V.; Dickson, M.; Ganjoo, K.; Ding, L.; Schmid, A.; Wagner, A.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase 2 clinical trial of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcomas
    Journal Article

    Attia, S.; Villalobos, V.; Hindi, N.; Wagner, A. J.; Chmielowski, B.; Oakley, G. J. 3rd; Peterson, P. M.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
    Cancers (2023)

    Fulltext@MSK | Save
  • SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Ballman, K. V.; Weiss, M. C.; Attia, S.; Wagner, M. J.; Pollack, S.; Choy, E.; Wagner, A. J.; Wilky, B. A.; Davis, L. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save